Literature DB >> 10528915

Apoptosis and the adaptive response in human lymphocytes.

S P Cregan1, D L Brown, R E Mitchel.   

Abstract

PURPOSE: To determine whether the sensitivity of human lymphocytes for apoptosis induced by either a membrane oxidizing agent or a DNA damaging agent is modified by an adaptive response.
MATERIALS AND METHODS: Peripheral blood lymphocytes from normal human donors were exposed to low doses of the DNA damaging agent gamma-radiation, or the membrane oxidizing agent t-butyl hydroperoxide (t-BuOOH), incubated for various times and then tested for their sensitivity to induction of apoptosis by a subsequent exposure to a high dose of either agent. Apoptosis was measured using a fluorescent assay of DNA unwinding or a terminal deoxynucleotide transferase assay.
RESULTS: The results show that Go lymphocytes pre-exposed to an adapting dose of radiation or DNA strand breaking agent are not protected but can become sensitized to subsequent apoptosis induced by radiation (a kinetically slow process). Inter- and intraindividual variations were observed. However, neither pre-exposure to radiation nor to a membrane oxidizing agent sensitized lymphocytes from any donor to apoptosis induced by a membrane oxidizing agent (a kinetically fast process).
CONCLUSIONS: Since an increase in the elimination of genetically damaged cells by apoptosis could reduce the risk of cancer from exposure to radiation or other DNA damaging agents, this cellular sensitization for apoptosis may represent a novel adaptive response mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528915     DOI: 10.1080/095530099139548

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  13 in total

Review 1.  Hormesis, an update of the present position.

Authors:  Lennart Johansson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-26       Impact factor: 9.236

2.  Will radiation-induced bystander effects or adaptive responses impact on the shape of the dose response relationships at low doses of ionizing radiation?

Authors:  William F Morgan
Journal:  Dose Response       Date:  2006-08-25       Impact factor: 2.658

3.  Human Health and the Biological Effects of Tritium in Drinking Water: Prudent Policy Through Science - Addressing the ODWAC New Recommendation.

Authors:  S Dingwall; C E Mills; N Phan; K Taylor; D R Boreham
Journal:  Dose Response       Date:  2011-02-22       Impact factor: 2.658

4.  The Ku-dependent non-homologous end-joining pathway contributes to low-dose radiation-stimulated cell survival.

Authors:  Xiaoyan Yu; Hongyan Wang; Ping Wang; Benjamin P C Chen; Ya Wang
Journal:  J Cell Physiol       Date:  2011-02       Impact factor: 6.384

5.  Immunomodulatory and cytoprotective role of RP-1 in gamma-irradiated mice.

Authors:  H C Goel; P K Agrawala; V Pathania; N Malhotra
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

6.  Detrimental and protective bystander effects: a model approach.

Authors:  H Schöllnberger; R E J Mitchel; J L Redpath; D J Crawford-Brown; W Hofmann
Journal:  Radiat Res       Date:  2007-11       Impact factor: 2.841

7.  Radiation-induced neoplastic transformation in vitro, hormesis and risk assessment.

Authors:  J Leslie Redpath; Eugene Elmore
Journal:  Dose Response       Date:  2006-12-06       Impact factor: 2.658

8.  Enhancement of bio-protective functions by low dose/dose-rate radiation.

Authors:  Kazuo Sakai; Takaharu Nomura; Yasuhiro Ina
Journal:  Dose Response       Date:  2006-09-23       Impact factor: 2.658

9.  An examination of radiation hormesis mechanisms using a multistage carcinogenesis model.

Authors:  H Schöllnberger; R D Stewart; R E J Mitchel; W Hofmann
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-10

10.  Non-induction of radioadaptive response in zebrafish embryos by neutrons.

Authors:  Candy Y P Ng; Eva Y Kong; Alisa Kobayashi; Noriyoshi Suya; Yukio Uchihori; Shuk Han Cheng; Teruaki Konishi; Kwan Ngok Yu
Journal:  J Radiat Res       Date:  2016-02-04       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.